FDA Adverse Event Malfunction Summary report: N

COBAS 6000 C501 MODULE

MDR report key: 2945039 · Received February 6, 2013

Report

Report Number
1823260-2013-00690
Event Type
Malfunction
Date Received
February 6, 2013
Date of Event
January 22, 2013
Report Date
February 11, 2013
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LEH
PMA / PMN Number
K060373
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A SPECIFIC ROOT CAUSE COULD NOT BE DETERMINED. CONTROL AND CALIBRATION DATA AROUND THE DATE OF OCCURRENCE DO NOT INDICATE A GENERAL PERFORMANCE ISSUE. THE WITHIN RUN CONTROL PRECISION WAS FOUND TO BE HIGH COMPARED TO INTERNAL DATA, WHICH INDICATES A POSSIBLE HARDWARE ISSUE. A HARDWARE ISSUE COULD NOT BE CONFIRMED BASED ON LIMITED DATA AVAILABLE FOR INVESTIGATION.

Additional Manufacturer Narrative · 1

IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA.

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT THEY RECEIVED AN ERRONEOUS RESULT FOR ONE PATIENT SAMPLE TESTED FOR VANCOMYCIN. THE SAMPLE INITIALLY RESULTED AS 1.2 UG/ML ACCOMPANIED BY A DATA FLAG. THE SAMPLE WAS REPEATED WITH AN INCREASED SAMPLE VOLUME, RESULTING AS 15.4 UG/ML. THE SAMPLE WAS REPEATED A SECOND TIME AND RESULTED AS 15.7 UG/ML. THE REPEAT RESULT WAS BELIEVED TO BE CORRECT. THE PATIENT WAS NOT ADVERSELY AFFECTED BY THE EVENT. THE VANCOMYCIN REAGENT LOT NUMBER WAS 66803201 WITH AN EXPIRATION DATE OF 06/30/2013. THE FIELD SERVICE REPRESENTATIVE COULD NOT DETERMINE A CAUSE FOR THE ISSUE. HE CLEANED AND INSPECTED THE SAMPLING FLOWPATH. HE EXAMINED THE CUVETTES. HE CHECKED PRECISION AND ACCURACY. THE PRECISON RESULTS WERE WITHIN GUIDELINES. HE PERFORMED DIAGNOSTIC AND MECHANICAL CHECKS. THE CUSTOMER RAN CALIBRATION AND QUALITY CONTROLS WITH PASSING RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
51014 COBAS 6000 C501 MODULE CLINICAL CHEMISTRY ANALYZER LEH ROCHE DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1